Acuta Capital Partners’s Tourmaline Bio TRML Stock Holding History

Acuta Capital Partners’s Portfolio TRML Stock Details TRML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$4.54M	Sell
2025 Q1	$6.49M	Buy
2024 Q4	$7.14M	Buy
2024 Q3	$8.54M	Buy
2024 Q2	$3.47M	Buy
2024 Q1	$5.98M	Buy
2023 Q4	$6.07M	Buy